01.03.2022 10:37:51

DGAP-AFR: SYNLAB AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

DGAP Preliminary announcement financial reports: SYNLAB AG / Preliminary announcement on the disclosure of financial statements
SYNLAB AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

01.03.2022 / 10:37
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


SYNLAB AG hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report of the group

Language: German
Date of disclosure: March 16, 2022
Address: https://ag.synlab.com/de/main-menu/finanzergebnisse

Language: English
Date of disclosure: March 16, 2022
Address: https://ag.synlab.com/financial-results


01.03.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: SYNLAB AG
Moosacher Straße 88
80809 Munich
Germany
Internet: www.synlab.com/

 
End of News DGAP News Service

1291143  01.03.2022 

fncls.ssp?fn=show_t_gif&application_id=1291143&application_name=news&site_id=smarthouse

Analysen zu SYNLAB AGmehr Analysen

05.12.23 SYNLAB Neutral JP Morgan Chase & Co.
08.11.23 SYNLAB Hold Jefferies & Company Inc.
29.09.23 SYNLAB Hold Jefferies & Company Inc.
25.08.23 SYNLAB Buy Deutsche Bank AG
10.08.23 SYNLAB Buy Deutsche Bank AG
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

SYNLAB AG 11,34 -0,53% SYNLAB AG